NasdaqGS - Nasdaq Real Time Price USD
HilleVax, Inc. (HLVX)
1.8800
-0.0400
(-2.08%)
As of 9:51:26 AM EDT. Market Open.
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
---|---|---|---|
BORKOWSKI ASTRID Officer | Sale | Feb 8, 2024 | 214,892 |
FRAZIER LIFE SCIENCES MANAGEMENT, L.P. Beneficial Owner of more than 10% of a Class of Security | Purchase | Apr 4, 2024 | -- |
FRAZIER LIFE SCIENCES X, L.P. Beneficial Owner of more than 10% of a Class of Security | Purchase | Apr 4, 2024 | -- |
HERSHBERG ROBERT M Chief Executive Officer | Sale | Feb 11, 2025 | 1,101,500 |
KOHLI ADITYA PH.D. Director | Sale | May 22, 2024 | 764,878 |
MALTBIE SHANE Chief Financial Officer | Sale | Feb 11, 2025 | 79,887 |
MCLOUGHLIN SEAN Chief Operating Officer | Purchase | Mar 28, 2024 | 1,250 |
Related Tickers
IKNA Ikena Oncology, Inc.
1.3750
+0.36%
PMVP PMV Pharmaceuticals, Inc.
1.0800
-0.92%
EPIX ESSA Pharma Inc.
1.6600
-2.33%
TBPH Theravance Biopharma, Inc.
10.56
-0.52%
RPTX Repare Therapeutics Inc.
1.4398
-0.01%
LVTX LAVA Therapeutics N.V.
1.3100
0.00%
ASMB Assembly Biosciences, Inc.
17.22
+0.70%
IPSC Century Therapeutics, Inc.
0.5721
-4.65%
SEER Seer, Inc.
2.0650
-3.04%
NERV Minerva Neurosciences, Inc.
1.8224
+2.36%